Osteomyelitis due to Mycobacterium haemophilum in an adult renal transplant recipient

Sompolinksy, 1978, Mycobacterium haemophilum sp. Nov., a new pathogen of humans, Int J Syst Bacteriol, 28, 67, 10.1099/00207713-28-1-67 Suabolle, 1996, Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans, Clin Microbiol Rev, 9, 435, 10.1128/CMR.9.4.435 Lindeboom, 2011, Clinical manifestations, diagnosis, and treatment of mycobacterium haemophilum infections, Clin Microbiol Rev, 24, 701, 10.1128/CMR.00020-11 Nookeu, 2019, Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum, Em Inf Dis, 25, 1648, 10.3201/eid2509.190430 Shah, 2001, Mycobacterium haemophilum in immunocompromised patients, Clin Inf Dis, 33, 330, 10.1086/321894 Tyner, 2017, Fifteen-year clinical experience with mycobacterium haemophilum at the mayo clinic: a case series, J Clin Tube Other Mycobact Dis, 8, 26, 10.1016/j.jctube.2017.06.002 Abad, 2016, Non-tuberculous mycobacteria infections in solid organ transplant recipients: an update, J Clin Tube Other Mycobact Dis, 4, 1, 10.1016/j.jctube.2016.04.001 Jang, 2007, Case of pyomyositis due to mycobacterium haemophilum in a renal transplant recipient, J Clin Microbiol, 45, 3847, 10.1128/JCM.01067-07 Pacholec, 2020, Fatal disseminated Mycobacterium haemophilum infection involving the central nervous system in a renal transplant recipient, J Clin Tube Other Mycobact Dis, 21 Brix, 2016, Disseminated Mycobacterium haemophilum infection in a renal transplant recipient, BMJ Case Rep, 10.1136/bcr-2016-216042 Falkinham, 2001, Factors Influencing Numbers of Mycobacterium avium, Mycobacterium intracellulare, and Other Mycobacteria in Drinking Water Systems, Appl Environ Micobiol, 67, 1225, 10.1128/AEM.67.3.1225-1231.2001 Vaerewijck, 2005, Mycobacteria in drinking water distribution systems: ecology and significance for human health, FEMS Microbiol Rev, 29, 911, 10.1016/j.femsre.2005.02.001 Lew, 2004, Osteomyelitis, Lancet, 364, 369, 10.1016/S0140-6736(04)16727-5 Griffith, 2007, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med, 175, 367, 10.1164/rccm.200604-571ST